TRNS
Transcat, Inc.
NASDAQ · Industrials · Industrial - Distribution · US
$85.48
−0.25%Aug 31, 2026, 13:00 UTC
Transcat, Inc. acquired Southeastern Biomedical, expanding its biomedical calibration channel.
Source:Aug 4, 2026, 22:41 UTC
Transcat, Inc. reported quarterly earnings of $0.51 per share for the quarter ended June 2026, beating the Zacks Consensus Estimate of $0.37 per share, and compared to $0.59 per share a year earlier.
Source:Aug 4, 2026, 00:00 UTC
Transcat Inc reported its Q1 FY2027 financial results with total consolidated revenue of $92.945 million, GAAP net income of $1.331 million, and diluted EPS of $0.14.
Source:Jun 22, 2026, 12:31 UTC
Transcat appointed Roy Simmons as Chief Strategy and Corporate Development Officer.
Source: